Estimated Excess Deaths Due to COVID-19 Among the Urban Population of Mainland China, December 2022 to January 2023

Author:

Raphson Leon1,Lipsitch Marc12ORCID

Affiliation:

1. Center for Communicable Disease Dynamics, Department of Epidemiology, Harvard T.H. Chan School of Public Health

2. Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA

Abstract

Background: Mainland China experienced a major surge in SARS-CoV-2 infections in December 2022–January 2023, but its impact on mortality was unclear given the underreporting of coronavirus disease 2019 deaths. Methods: Using obituary data from the Chinese Academy of Engineering (CAE), we estimated the excess death rate among senior CAE members by taking the difference between the observed rate of all-cause death in December 2022–January 2023 and the expected rate for the same months in 2017–2022, by age groups. We used this to extrapolate an estimate of the number of excess deaths in December 2022–January 2023 among urban dwellers in Mainland China. Results: In December 2022–January 2023, we estimated excess death rates of 0.94 per 100 persons (95% confidence interval [CI] = −0.54, 3.16) in CAE members aged 80–84 years, 3.95 (95% CI = 0.50, 7.84) in 85–89 years, 10.35 (95% CI = 3.59, 17.71) in 90–94 years, and 16.88 (95% CI = 0.00, 34.62) in 95 years and older. Using our baseline assumptions, this extrapolated to 917,000 (95% CI = 425,000, 1.45 million) excess deaths among urban dwellers in Mainland China, much higher than the 81,000 in-hospital deaths officially reported from 9 December 2022 to 30 January 2023. Conclusions: As in many jurisdictions, we estimate that the coronavirus disease 2019 pandemic had a much wider impact on mortality than what was officially documented in Mainland China.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference8 articles.

1. Modeling transmission of SARS-CoV-2 omicron in China.;Cai;Nat Med,2022

2. Modelling the adjustment of COVID-19 response and exit from dynamic zero-COVID in China.;Leung;medRxiv,2022

3. Excess all-cause mortality in China after ending the zero COVID policy.;Xiao;JAMA Netw Open,2023

4. Estimate of COVID-19 deaths, China, December 2022–February 2023.;Du;Emerg Infect Dis,2023

5. Changes in all-cause and cause-specific excess mortality before and after the Omicron outbreak of COVID-19 in Hong Kong.;Chong;J Glob Health,2023

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3